1. Home
  2. TMDX vs NNI Comparison

TMDX vs NNI Comparison

Compare TMDX & NNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMDX
  • NNI
  • Stock Information
  • Founded
  • TMDX 1998
  • NNI 1978
  • Country
  • TMDX United States
  • NNI United States
  • Employees
  • TMDX N/A
  • NNI N/A
  • Industry
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • NNI Finance: Consumer Services
  • Sector
  • TMDX Health Care
  • NNI Finance
  • Exchange
  • TMDX Nasdaq
  • NNI Nasdaq
  • Market Cap
  • TMDX 4.7B
  • NNI 4.1B
  • IPO Year
  • TMDX 2019
  • NNI 2003
  • Fundamental
  • Price
  • TMDX $88.36
  • NNI $109.64
  • Analyst Decision
  • TMDX Buy
  • NNI Hold
  • Analyst Count
  • TMDX 10
  • NNI 1
  • Target Price
  • TMDX $138.20
  • NNI $98.00
  • AVG Volume (30 Days)
  • TMDX 2.2M
  • NNI 51.6K
  • Earning Date
  • TMDX 10-28-2024
  • NNI 11-07-2024
  • Dividend Yield
  • TMDX N/A
  • NNI 1.02%
  • EPS Growth
  • TMDX N/A
  • NNI N/A
  • EPS
  • TMDX 0.94
  • NNI 3.11
  • Revenue
  • TMDX $401,090,000.00
  • NNI $1,260,967,000.00
  • Revenue This Year
  • TMDX $83.25
  • NNI N/A
  • Revenue Next Year
  • TMDX $26.27
  • NNI $3.50
  • P/E Ratio
  • TMDX $94.29
  • NNI $35.48
  • Revenue Growth
  • TMDX 109.09
  • NNI 3.60
  • 52 Week Low
  • TMDX $63.86
  • NNI $82.22
  • 52 Week High
  • TMDX $177.37
  • NNI $127.32
  • Technical
  • Relative Strength Index (RSI)
  • TMDX 31.88
  • NNI 47.97
  • Support Level
  • TMDX $82.70
  • NNI $108.89
  • Resistance Level
  • TMDX $98.88
  • NNI $127.32
  • Average True Range (ATR)
  • TMDX 5.52
  • NNI 2.78
  • MACD
  • TMDX 1.30
  • NNI -0.63
  • Stochastic Oscillator
  • TMDX 15.58
  • NNI 20.35

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

About NNI Nelnet Inc.

Nelnet Inc is a United States based company engaged in these four segments; Loan Servicing and Systems focuses on student and consumer loan origination services and servicing, loan origination and servicing-related technology solutions, and outsourcing business services; Education Technology, Services, and Payment Processing provides education services, payment technology, and community management solutions for K-12 schools, institutions, churches, and businesses; Asset Generation and Management Includes the acquisition and management of student and other loan assets; and Nelnet Bank focuses on the private education and unsecured consumer loan markets. Loan Servicing and Systems Segment derives majority of the company's revenue.

Share on Social Networks: